Literature DB >> 12776193

ZNF198 protein, involved in rearrangement in myeloproliferative disease, forms complexes with the DNA repair-associated HHR6A/6B and RAD18 proteins.

Padmaja Kunapuli1, Robert Somerville, Ivan H Still, John K Cowell.   

Abstract

A highly specific t(8;13)(p11;q12) translocation has been consistently identified in bone marrow cells from patients with an atypical myeloproliferative disease that is associated with peripheral blood eosinophila and T- or B-cell leukemias. In all patients analysed to date, the translocation event results in a chimeric gene in which the atypical zinc-finger domain of ZNF198 is fused to the N-terminal end of the catalytic domain of the FGFR1 receptor tyrosine kinase. To understand more about the consequences of this rearrangement we have investigated the normal function of the ZNF198 gene. Using yeast two-hybrid analysis we identified HHR6 as a protein binding partner and confirmed this using immunoprecipitation studies. The ZNF198/FGFR1 fusion protein also binds to HHR6. We demonstrate here that the human RAD18 is also present in the ZNF198/HHR6 protein complex, although it does not coimmunoprecipitate with the fusion kinase. Cells expressing the fusion kinase gene show a marked increased sensitivity to UVB irradiation, suggesting that it acts in a dominant-negative way to affect DNA repair. These observations support the idea that ZNF198, through its interaction with HHR6 and RAD18, may be involved in the DNA repair process.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12776193     DOI: 10.1038/sj.onc.1206408

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

1.  Induction of the plasminogen activator inhibitor-2 in cells expressing the ZNF198/FGFR1 fusion kinase that is involved in atypical myeloproliferative disease.

Authors:  Chitta S Kasyapa; Padmaja Kunapuli; Lesleyann Hawthorn; John K Cowell
Journal:  Blood       Date:  2006-01-12       Impact factor: 22.113

2.  Proteins ZNF198 and SUZ12 are down-regulated in hepatitis B virus (HBV) X protein-mediated hepatocyte transformation and in HBV replication.

Authors:  Wen-Horng Wang; Leo L Studach; Ourania M Andrisani
Journal:  Hepatology       Date:  2011-04       Impact factor: 17.425

3.  BRCTx is a novel, highly conserved RAD18-interacting protein.

Authors:  David J Adams; Louise van der Weyden; Fanni V Gergely; Mark J Arends; Bee Ling Ng; David Tannahill; Roland Kanaar; Andrea Markus; Brian J Morris; Allan Bradley
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

4.  Arsenic trioxide affects signal transducer and activator of transcription proteins through alteration of protein tyrosine kinase phosphorylation.

Authors:  Meir Wetzler; Michael T Brady; Erin Tracy; Zhang-Rong Li; Kathleen A Donohue; Kieran L O'Loughlin; Yijun Cheng; Amir Mortazavi; Amy A McDonald; Padmaja Kunapuli; Paul K Wallace; Maria R Baer; John K Cowell; Heinz Baumann
Journal:  Clin Cancer Res       Date:  2006-11-15       Impact factor: 12.531

5.  Analysis of transcriptional modulation of the presenilin 1 gene promoter by ZNF237, a candidate binding partner of the Ets transcription factor ERM.

Authors:  Martine Pastorcic; Hriday K Das
Journal:  Brain Res       Date:  2006-11-28       Impact factor: 3.252

6.  Phosphorylation of the SSBP2 and ABL proteins by the ZNF198-FGFR1 fusion kinase seen in atypical myeloproliferative disorders as revealed by phosphopeptide-specific MS.

Authors:  Chitta Kasyapa; Ting-Lei Gu; Lalitha Nagarajan; Lalitha Natarajan; Roberto Polakiewicz; John K Cowell
Journal:  Proteomics       Date:  2009-08       Impact factor: 3.984

7.  Crypton transposons: identification of new diverse families and ancient domestication events.

Authors:  Kenji K Kojima; Jerzy Jurka
Journal:  Mob DNA       Date:  2011-10-19

Review 8.  Tyrosine kinase gene fusions in cancer: translating mechanisms into targeted therapies.

Authors:  Sandrine Medves; Jean-Baptiste Demoulin
Journal:  J Cell Mol Med       Date:  2012-02       Impact factor: 5.310

9.  Characterization of the SUMO-binding activity of the myeloproliferative and mental retardation (MYM)-type zinc fingers in ZNF261 and ZNF198.

Authors:  Catherine M Guzzo; Alison Ringel; Eric Cox; Ijeoma Uzoma; Heng Zhu; Seth Blackshaw; Cynthia Wolberger; Michael J Matunis
Journal:  PLoS One       Date:  2014-08-18       Impact factor: 3.240

10.  The Chromatin Regulator ZMYM2 Restricts Human Pluripotent Stem Cell Growth and Is Essential for Teratoma Formation.

Authors:  Elyad Lezmi; Uri Weissbein; Tamar Golan-Lev; Malka Nissim-Rafinia; Eran Meshorer; Nissim Benvenisty
Journal:  Stem Cell Reports       Date:  2020-06-18       Impact factor: 7.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.